Story

Doximity Stock Surges Over 60% on Revenue Beat and Upgraded Outlook

ENTHMSVIIDZHZH-TWJAKOHI
Aug 7, 20262 min read
Doximity Stock Surges Over 60% on Revenue Beat and Upgraded Outlook
Text size
Background

Shares of Doximity (NYSE: DOCS) surged 66.0% in pre-market trading after the digital platform for medical professionals reported stronger-than-expected fiscal first-quarter results and raised its annual forecast, signaling that its investments in artificial intelligence are beginning to drive growth.

Strong Q1 Results Defy Expectations

For its fiscal first quarter of 2027, Doximity reported revenue of $156.6 million, a 7% year-over-year increase that surpassed the Wall Street consensus of $151.7 million. The company's profitability also exceeded its own projections, with adjusted EBITDA reaching $75 million, representing a 48% margin that was 8 percentage points above the high end of its guidance.

While adjusted earnings per share of $0.29 came in one cent below the $0.30 analyst estimate, investors largely looked past the minor miss, focusing instead on the strong top-line performance and positive operational updates.

AI Initiatives Fuel Optimism

Management attributed the strong results to growing commercial traction for its suite of artificial intelligence tools. CEO Jeff Tangney highlighted that the company's AI clinical assistant, Doximity Ask, achieved a top ranking on a key industry benchmark. The company also noted that its AI Search product for pharmaceutical clients is gaining momentum.

Sample IUX Markets – In-articleAd

Reflecting this positive trend, Doximity raised its full-year revenue guidance by $6 million to a new range of $671 million to $681 million. The upgraded outlook suggests management is confident that AI-driven user engagement will translate into durable revenue growth, a significant reversal from the more cautious tone it struck in the previous quarter.

Market Context and Investor Reaction

The dramatic stock reaction was amplified by its low starting point. Shares had been trading near their 52-week low of $17.15 following a disappointing report and guidance cut last quarter. This set a low bar for a positive surprise and likely triggered significant short-covering as traders rushed to close out bearish bets.

The results have effectively reframed the narrative for investors, shifting the perception of the company's AI spending from a drag on margins to a potent catalyst for future growth. This has prompted a sharp reassessment of the stock's valuation from its recently depressed levels.

Read next

More on Stocks
Back to latest news

LATEST